VIOLETTE SHELIA M. (Chief Scientific Officer) sold 4.8% of their position (2.81K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $12.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2026ACC: 0001193125-26-083584
Officer· Chief Scientific Officer
Since Feb 2026
-2.81K
Net shares
Net seller
$12.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.81K
Price / share
$4.51
Trade value
$12.71K
% of position
4.8%
2/25/2026
58.38K→55.57K
Total
Net shares
−2.81K
Net value
-$12.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | S · Sale | −2.81K | $4.51 | $12.71K | 4.8% | 58.38K | 55.57K |
| Total | −2.81K | -$12.71K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned36.28K
Total
36.28K indirect36.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.28K | Indirect |
| Total | 36.28K | 36.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported